Treatment with fezolinetant resulted in statistically significant reductions in the frequency and severity of VMS and improvements in quality of life TOKYO, March 13, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today…

NEW YORK, March 13, 2023 /PRNewswire/ — The global enterprise session border controller market size is estimated to grow by USD 252.34 million from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 8.07% during the forecast period. The increasing number…

DUBLIN, March 13, 2023 /PRNewswire/ — The “Switzerland Social Commerce Market Intelligence and Future Growth Dynamics Databook – 50+ KPIs on Social Commerce Trends by End-Use Sectors, Operational KPIs, Retail Product Dynamics, and Consumer Demographics – Q1 2023 Update” report has been…

SHANGHAI, March 13, 2023 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”) announced today that its partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) reported positive topline results from the global, randomized,…

DUBLIN, March 13, 2023 /PRNewswire/ — The “Global Light Electric Vehicles Market Size, Share & Industry Trends Analysis Report By Vehicle Category (2-wheelers, 3-wheelers, and 4-wheelers), By Vehicle Type, By Component Type, By Application, By Power Output, By Regional Outlook and…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.